de Barclays TG Therapeutics TGTX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 52.6 M | Comprar |
957,848
+841,191
| +721% | +USD 34.4 M | 0.01% | 715 |
|
|
2026
Q1 | USD 3.88 M | Vender |
116,657
-330,063
| -74% | -USD 9.8 M | ﹤0.01% | 1976 |
|
|
2025
Q4 | USD 13.3 M | Vender |
446,720
-11,505
| -3% | -USD 376 k | ﹤0.01% | 1486 |
|
|
2025
Q3 | USD 16.6 M | Vender |
458,225
-162,321
| -26% | -USD 5.35 M | ﹤0.01% | 1343 |
|
|
2025
Q2 | USD 22.3 M | Comprar |
620,546
+367,452
| +145% | +USD 13.7 M | 0.01% | 1072 |
|
|
2025
Q1 | USD 10 M | Vender |
253,094
-64,469
| -20% | -USD 2.17 M | ﹤0.01% | 1407 |
|
|
2024
Q4 | USD 9.6 M | Vender |
317,563
-29,494
| -8% | -USD 846 k | ﹤0.01% | 1608 |
|
|
2024
Q3 | USD 8.12 M | Comprar |
347,057
+207,723
| +149% | +USD 4.54 M | ﹤0.01% | 1633 |
|
|
2024
Q2 | USD 2.48 M | Vender |
139,334
-17,046
| -11% | -USD 272 k | ﹤0.01% | 1992 |
|
|
2024
Q1 | USD 2.38 M | Vender |
156,380
-271,633
| -63% | -USD 4.33 M | ﹤0.01% | 2428 |
|
|
2023
Q4 | USD 7.31 M | Vender |
428,013
-9,629
| -2% | -USD 112 k | ﹤0.01% | 1773 |
|
|
2023
Q3 | USD 3.66 M | Vender |
437,642
-45,440
| -9% | -USD 633 k | ﹤0.01% | 1524 |
|
|
2023
Q2 | USD 12 M | Vender |
483,082
-307,011
| -39% | -USD 7.93 M | 0.01% | 915 |
|
|
2023
Q1 | USD 11.9 M | Comprar |
790,093
+274,125
| +53% | +USD 4.16 M | 0.01% | 1085 |
|
|
2022
Q4 | USD 6.1 M | Vender |
515,968
-76,161
| -13% | -USD 553 k | ﹤0.01% | 1484 |
|
|
2022
Q3 | USD 3.5 M | Comprar |
592,129
+262,360
| +80% | +USD 1.72 M | ﹤0.01% | 1382 |
|
|
2022
Q2 | USD 1.4 M | Comprar |
329,769
+189,478
| +135% | +USD 1.18 M | ﹤0.01% | 2097 |
|
|
2022
Q1 | USD 1.33 M | Vender |
140,291
-78,104
| -36% | -USD 904 k | ﹤0.01% | 2181 |
|
|
2021
Q4 | USD 4.15 M | Comprar |
218,395
+118,164
| +118% | +USD 3.07 M | ﹤0.01% | 1843 |
|
|
2021
Q3 | USD 3.34 M | Comprar |
100,231
+75,588
| +307% | +USD 2.34 M | ﹤0.01% | 1921 |
|
|
2021
Q2 | USD 956 k | Vender |
24,643
-96,666
| -80% | -USD 3.8 M | ﹤0.01% | 2689 |
|
|
2021
Q1 | USD 5.85 M | Comprar |
121,309
+60,120
| +98% | +USD 2.89 M | ﹤0.01% | 1395 |
|
|
2020
Q4 | USD 3.18 M | Vender |
61,189
-420,827
| -87% | -USD 14.2 M | ﹤0.01% | 1862 |
|
|
2020
Q3 | USD 12.9 M | Vender |
482,016
-441,933
| -48% | -USD 10.2 M | 0.01% | 918 |
|
|
2020
Q2 | USD 18 M | Comprar |
923,949
+63,030
| +7% | +USD 1.02 M | 0.01% | 689 |
|
|
2020
Q1 | USD 8.47 M | Comprar |
860,919
+67,497
| +9% | +USD 853 k | 0.01% | 1094 |
|
|
2019
Q4 | USD 8.81 M | Comprar |
793,422
+631,210
| +389% | +USD 4.8 M | ﹤0.01% | 1498 |
|
|
2019
Q3 | USD 910 k | Comprar |
162,212
+96,449
| +147% | +USD 672 k | ﹤0.01% | 3755 |
|
|
2019
Q2 | USD 569 k | Comprar |
65,763
+47,722
| +265% | +USD 361 k | ﹤0.01% | 4207 |
|
|
2019
Q1 | USD 145 k | Vender |
18,041
-33,217
| -65% | -USD 180 k | ﹤0.01% | 5070 |
|
|
2018
Q4 | USD 210 k | Comprar |
51,258
+26,377
| +106% | +USD 131 k | ﹤0.01% | 4541 |
|
|
2018
Q3 | USD 140 k | Comprar |
24,881
+15,298
| +160% | +USD 175 k | ﹤0.01% | 5285 |
|
|
2018
Q2 | USD 126 k | Vender |
9,583
-13,721
| -59% | -USD 189 k | ﹤0.01% | 5083 |
|
|
2018
Q1 | USD 331 k | Comprar |
23,304
+12,053
| +107% | +USD 154 k | ﹤0.01% | 4372 |
|
|
2017
Q4 | USD 93 k | Vender |
11,251
-14,670
| -57% | -USD 128 k | ﹤0.01% | 5297 |
|
|
2017
Q3 | USD 307 k | Vender |
25,921
-28,156
| -52% | -USD 321 k | ﹤0.01% | 4054 |
|
|
2017
Q2 | USD 543 k | Comprar |
54,077
+53,265
| +6,560% | +USD 596 k | ﹤0.01% | 3446 |
|
|
2017
Q1 | USD 9 k | Vender |
812
-1,301
| -62% | -USD 9.34 k | ﹤0.01% | 6118 |
|
|
2016
Q4 | USD 10 k | Comprar |
2,113
+1,183
| +127% | +USD 6.94 k | ﹤0.01% | 5904 |
|
|
2016
Q3 | USD 8 k | Comprar |
930
+889
| +2,168% | +USD 5.72 k | ﹤0.01% | 5873 |
|
|
2016
Q2 | USD 0 | Vender |
41
-12,034
| -100% | -USD 97.8 k | ﹤0.01% | 6626 |
|
|
2016
Q1 | USD 97 k | Comprar |
12,075
+11,894
| +6,571% | +USD 104 k | ﹤0.01% | 4375 |
|
|
2015
Q4 | USD 2 k | Vender |
181
-1,633
| -90% | -USD 20.6 k | ﹤0.01% | 5765 |
|
|
2015
Q3 | USD 18 k | Vender |
1,814
-4,606
| -72% | -USD 68.6 k | ﹤0.01% | 5512 |
|
|
2015
Q2 | USD 103 k | Comprar |
6,420
+554
| +9% | +USD 8.77 k | ﹤0.01% | 4652 |
|
|
2015
Q1 | USD 87 k | Vender |
5,866
-177,685
| -97% | -USD 2.69 M | ﹤0.01% | 4944 |
|
|
2014
Q4 | USD 2.75 M | Comprar |
183,551
+182,079
| +12,369% | +USD 2.37 M | ﹤0.01% | 2241 |
|
|
2014
Q3 | USD 14 k | Comprar |
1,472
+1,067
| +263% | +USD 9.9 k | ﹤0.01% | 6703 |
|
|
2014
Q2 | USD 4 k | Vender |
405
-277
| -41% | -USD 1.77 k | ﹤0.01% | 7206 |
|
|
2014
Q1 | USD 4 k | Comprar |
682
+337
| +98% | +USD 2 k | ﹤0.01% | 7286 |
|
|
2013
Q4 | USD 1 k | Vender |
345
-236
| -41% | -USD 953 | ﹤0.01% | 7451 |
|
|
2013
Q3 | USD 3 k | Vender |
581
-89
| -13% | -USD 544 | ﹤0.01% | 7122 |
|
|
2013
Q2 | USD 4 k | Comprar |
+670
| Nuevas | +USD 4.29 k | ﹤0.01% | 7413 |
|
Otros fondos que tienen TGTX en su cartera
Posición de Barclays en TGTX: resumen de T2 2026
Barclays aumentó su participación en TG Therapeutics (TGTX) en 721% durante T2 2026, al comprar aproximadamente USD 34.4 M y elevar la posición a 957,848 acciones con un valor de USD 52.6 M. La posición representa 0.01% de la cartera y ocupa el puesto #715.
Barclays reportó por primera vez una posición en TGTX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 432 fondos que sigue Wall St. Rank mantienen una posición en TGTX.
- Al cierre de T2 2026, Barclays tenía 957,848 acciones de TG Therapeutics con un valor de USD 52.6 M.
- Barclays compró 841,191 acciones de TG Therapeutics en T2 2026, por un monto estimado de USD 34.4 M.
- TG Therapeutics representó 0.01% de la cartera de Barclays en T2 2026 y fue su posición número 715.
- Barclays reportó por primera vez una posición en TG Therapeutics en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 432 fondos que sigue Wall St. Rank tenían TG Therapeutics en cartera.
Según el Informe 13F de Barclays correspondiente a T2 2026, presentado el 14 ago 2026.